Literature DB >> 28236637

The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study.

E Burte1,2,3, J Bousquet1,2,4, V Siroux5,6,7, J Just8,9, B Jacquemin1,2,3,10,11, R Nadif1,2.   

Abstract

BACKGROUND: Mono- and polysensitization are different IgE-mediated allergic phenotypes in children. Allergic sensitization is associated with both allergic asthma and allergic rhinitis, however, associations between the sensitization pattern and particularly polysensitization with asthma and rhinitis remains poorly studied in adults. AIM: The aim of this study was to assess how the allergic sensitization pattern associates with asthma, rhinitis and their multimorbidity.
METHODS: 1199 adults from the EGEA study, with extensive phenotypic characterization and all data available on skin prick tests to 10 allergens, total IgE and blood eosinophils were included. Using questionnaires only, participants were classified into 6 groups: asymptomatic (no asthma, no rhinitis), non-allergic rhinitis alone, allergic rhinitis alone, asthma alone, asthma+non-allergic rhinitis and asthma+allergic rhinitis. Mono- and polysensitization were defined by a positive skin prick test to one or more than one allergen respectively.
RESULTS: Asymptomatic participants and those with non-allergic rhinitis alone were mostly non-sensitized (around 72%) while around 12% were polysensitized. Between 32% and 43% of participants with allergic rhinitis alone, asthma alone and asthma+non-allergic rhinitis were non-sensitized and between 37% and 46% of them were polysensitized. 65% of the participants with asthma+allergic rhinitis were polysensitized. The level of total IgE followed a similar trend to that of allergic sensitization. Eosinophils were increased in asthma, especially when associated with rhinitis. Nasal symptoms were more severe and eczema more common in participants with both asthma and allergic rhinitis than in the other groups.
CONCLUSIONS: Allergic sensitization and particularly polysensitization rates widely differ according to asthma and rhinitis status. This study emphasized the importance of taking into account multimorbidity between asthma and rhinitis and showed that allergic sensitization is not a dichotomic variable.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  allergic sensitization; asthma; monosensitization; multimorbidity; polysensitization; rhinitis

Mesh:

Substances:

Year:  2017        PMID: 28236637     DOI: 10.1111/cea.12897

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

1.  Perceived Versus Actual Aeroallergen Sensitization in Urban Children.

Authors:  Michele N Pham; Jade Andrade; Michelle Mishoe; Yoojin Chun; Supinda Bunyavanich
Journal:  J Allergy Clin Immunol Pract       Date:  2019-01-14

Review 2.  POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project.

Authors:  Jean Bousquet; Josep M Anto; Isabella Annesi-Maesano; Toni Dedeu; Eve Dupas; Jean-Louis Pépin; Landry Stephane Zeng Eyindanga; Sylvie Arnavielhe; Julia Ayache; Xavier Basagana; Samuel Benveniste; Nuria Calves Venturos; Hing Kin Chan; Mehdi Cheraitia; Yves Dauvilliers; Judith Garcia-Aymerich; Ingrid Jullian-Desayes; Chitra Dinesh; Daniel Laune; Jade Lu Dac; Ismael Nujurally; Giovanni Pau; Robert Picard; Xavier Rodo; Renaud Tamisier; Michael Bewick; Nils E Billo; Wienczyslawa Czarlewski; Joao Fonseca; Ludger Klimek; Oliver Pfaar; Jean-Marc Bourez
Journal:  Clin Transl Allergy       Date:  2018-09-17       Impact factor: 5.871

3.  Incidence and remission of aeroallergen sensitization in adults in Northern Finland: 15 years longitudinal study.

Authors:  Anna Karoliina Haarala; Suvi-Päivikki Sinikumpu; Eeva Vaaramo; Jari Jokelainen; Markku Timonen; Juha Auvinen; Juha Pekkanen; Jussi Lampi; Laura Huilaja
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

4.  Allergic multimorbidity is associated with self-reported anaphylaxis in adults-A cross-sectional questionnaire study.

Authors:  Tuuli Thomander; Sanna Toppila-Salmi; Johanna Salimäki; Juha Jantunen; Heini Huhtala; Paula Pallasaho; Paula Kauppi
Journal:  Clin Transl Allergy       Date:  2022-07-21       Impact factor: 5.657

5.  A Childhood Farm Environment Protects from Allergic Sensitization until Middle Age but Not from New-Onset Sensitization in Adulthood: A 15 Year Longitudinal Study.

Authors:  Anna Karoliina Haarala; Suvi-Päivikki Sinikumpu; Eeva Vaaramo; Jari Jokelainen; Markku Timonen; Juha Auvinen; Juha Pekkanen; Laura Huilaja
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

6.  Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis.

Authors:  Viiu Blöndal; Fredrik Sundbom; Magnus P Borres; Marieann Högman; Kjell Alving; Andrei Malinovschi; Christer Janson
Journal:  Clin Transl Allergy       Date:  2020-02-21       Impact factor: 5.871

7.  Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA2 LEN study.

Authors:  Viiu Blöndal; Andrei Malinovschi; Fredrik Sundbom; Anna James; Roelinde Middelveld; Karl A Franklin; Bo Lundbäck; Christer Janson
Journal:  Clin Exp Allergy       Date:  2020-10-25       Impact factor: 5.018

8.  Allergic sensitization pattern of patients in Brazil.

Authors:  Carolina Sanchez Aranda; Renata R Cocco; Felipe F Pierotti; Emanuel Sarinho; Flávio Sano; Arnaldo Porto; Nelson Rosário; Herberto J Chong Neto; Ekaterini Goudouris; Lillian S Moraes; Neusa F Wandalsen; Marcia C Mallozi; Antônio C Pastorino; Jackeline M Franco; Maria L Chavarria; Magnus Borres; Dirceu Solé
Journal:  J Pediatr (Rio J)       Date:  2020-09-25       Impact factor: 2.990

Review 9.  Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.

Authors:  Victoria S Benson; Sylvia Hartl; Neil Barnes; Nicholas Galwey; Melissa K Van Dyke; Namhee Kwon
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.